ALADDIN was a European collaborative project created to make paediatric oncology drug development knowledge more accessible to a wide range of stakeholders. Through a dedicated online platform, the project brought together experts from academia, regulatory authorities, patient organisations and industry to deliver engaging educational webinars and learning modules covering how medicines for children with cancer are developed. The project formally concluded in 2025, with all deliverables completed and validated, and the focus has shifted to sustaining and promoting the educational resources created. We invite you to explore the links below to learn more about the ALADDIN project, or to visit the education portal and access the training materials directly.
VISIT WEBSITE
VIEW PORTAL
